These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10614623)

  • 1. The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction.
    Tivesten A; Bollano E; Caidahl K; Kujacic V; Sun XY; Hedner T; Hjalmarson A; Bengtsson BA; Isgaard J
    Endocrinology; 2000 Jan; 141(1):60-6. PubMed ID: 10614623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar cardiovascular effects of growth hormone and insulin-like growth factor-I in rats after experimental myocardial infarction.
    Tivesten A; Caidahl K; Kujacic V; Sun XY; Hedner T; Bengtsson BA; Isgaard J
    Growth Horm IGF Res; 2001 Jun; 11(3):187-95. PubMed ID: 11735233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.
    Ghigo E; Gianotti L; Arvat E; Ramunni J; Valetto MR; Broglio F; Rolla M; Cavagnini F; Müller EE
    J Clin Endocrinol Metab; 1999 Jan; 84(1):285-90. PubMed ID: 9920097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone-independent cardioprotective effects of hexarelin in the rat.
    Locatelli V; Rossoni G; Schweiger F; Torsello A; De Gennaro Colonna V; Bernareggi M; Deghenghi R; Müller EE; Berti F
    Endocrinology; 1999 Sep; 140(9):4024-31. PubMed ID: 10465272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hexarelin, a growth hormone secretagogue, protects the isolated rat heart from ventricular dysfunction produced by exposure to calcium-free medium.
    Rossoni G; Locatelli V; Gennaro Colonna Vd ; Müller EE; Berti F
    Pharmacol Res; 2000 Aug; 42(2):129-36. PubMed ID: 10887041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone improves cardiac function in rats with experimental myocardial infarction.
    Isgaard J; Kujacic V; Jennische E; Holmäng A; Sun XY; Hedner T; Hjalmarson A; Bengtsson BA
    Eur J Clin Invest; 1997 Jun; 27(6):517-25. PubMed ID: 9229233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human growth hormone secreted from tissue-engineered bioartificial muscle improves left ventricular function in rat with acute myocardial infarction.
    Rong SL; Wang YJ; Wang XL; Lu YX; Chang C; Wang FZ; Liu QY; Liu XY; Gao YZ; Mi SH
    Chin Med J (Engl); 2009 Oct; 122(19):2352-9. PubMed ID: 20079139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acute hexarelin administration on cardiac performance in patients with coronary artery disease during by-pass surgery.
    Broglio F; Guarracino F; Benso A; Gottero C; Prodam F; Granata R; Avogadri E; Muccioli G; Deghenghi R; Ghigo E
    Eur J Pharmacol; 2002 Jul; 448(2-3):193-200. PubMed ID: 12144941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GH replacement fails to improve ventricular function in hypophysectomized rats with myocardial infarction.
    Shen YT; Wiedmann RT; Lynch JJ; Grossman W; Johnson RG
    Am J Physiol; 1996 Nov; 271(5 Pt 2):H1721-7. PubMed ID: 8945883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone improves bioenergetics and decreases catecholamines in postinfarct rat hearts.
    Omerovic E; Bollano E; Mobini R; Kujacic V; Madhu B; Soussi B; Fu M; Hjalmarson A; Waagstein F; Isgaard J
    Endocrinology; 2000 Dec; 141(12):4592-9. PubMed ID: 11108272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition.
    Jin H; Yang R; Gillett N; Clark RG; Ko A; Paoni NF
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):420-5. PubMed ID: 8583784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of an intact growth hormone/insulin-like growth factor 1 axis for normal post-infarction healing: studies in dwarf rats.
    Cittadini A; Grossman JD; Strömer H; Katz SE; Morgan JP; Douglas PS
    Endocrinology; 2001 Jan; 142(1):332-8. PubMed ID: 11145596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
    Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction.
    Kanashiro-Takeuchi RM; Tziomalos K; Takeuchi LM; Treuer AV; Lamirault G; Dulce R; Hurtado M; Song Y; Block NL; Rick F; Klukovits A; Hu Q; Varga JL; Schally AV; Hare JM
    Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2604-9. PubMed ID: 20133784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective beta(1)-blockade improves cardiac bioenergetics and function and decreases neuroendocrine activation in rats during early postinfarct remodeling.
    Omerovic E; Bollano E; Mobini R; Madhu B; Kujacic V; Soussi B; Hjalmarson A; Waagstein F
    Biochem Biophys Res Commun; 2001 Feb; 281(2):491-8. PubMed ID: 11181074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Growth Hormone Secretagogue Hexarelin Protects Rat Cardiomyocytes From in vivo Ischemia/Reperfusion Injury Through Interleukin-1 Signaling Pathway.
    Huang J; Li Y; Zhang J; Liu Y; Lu Q
    Int Heart J; 2017 Apr; 58(2):257-263. PubMed ID: 28321024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat.
    Duerr RL; McKirnan MD; Gim RD; Clark RG; Chien KR; Ross J
    Circulation; 1996 Jun; 93(12):2188-96. PubMed ID: 8925588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
    Minczykowski A; Gryczynska M; Ziemnicka K; Czepczynski R; Sowinski J; Wysocki H
    Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone alone or combined with metoprolol preserves cardiac function after myocardial infarction in rats.
    Bollano E; Bergh CH; Kjellström C; Omerovic E; Kujacic V; Caidahl K; Bengtsson BA; Waagstein F; Isgaard J
    Eur J Heart Fail; 2001 Dec; 3(6):651-60. PubMed ID: 11738216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hexarelin, but not growth hormone, protects heart from damage induced in vitro by calcium deprivation replenishment.
    Torsello A; Rossoni G; Locatelli V; De Gennaro Colonna V; Bernareggi M; Francolini M; Müller EE; Berti F
    Endocrine; 2001 Feb; 14(1):109-12. PubMed ID: 11322492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.